Virios doses first subject in long Covid antiviral trial
IMC-2 merges valacyclovir and celecoxib together to hinder the herpes virus from activating and replicating.
Infectious Disease
Latest in
Infectious Disease
MedStar and Georgetown scientists to conduct acute rhinosinusitis trial
The randomised trial will enrol over 3,700 individuals with acute rhinosinusitis.
Monkeypox outbreak poses increased risk for 417,000 men who have sex with men
Concern over the monkeypox virus is higher among men who have sex with men (MSM) due to the nature of…
By
Cocrystal selects hVIVO as CRO for Phase IIa Influenza antiviral trial
The trial of CC-42344 in participants who are challenged with influenza A is planned to begin in the second half…
Frontier reports positive Phase I Covid-19 drug data
In the trial, up to 400mg daily dose of FB2001 was found to be safe and well tolerated.
Novavax begins Phase IIb/III Covid-19 vaccine trial in children
The trial will enrol 3,600 participants in Mexico, US, Argentina, Spain, UK, Colombia, South Africa, Philippines and Brazil.
Ascletis receives FDA nod for Phase Ib Covid-19 oral drug trial
The trial will analyse the safety, tolerability, pharmacokinetics and initial efficacy of ASC10 tablets in Covid-19 patients.
DCRI tasked as data centre for NIH long Covid studies
The institute will partner with RTI International to expedite the trial process and launch multi-intervention studies.